ORIENT BIO Inc.
002630.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$48.56B
Close$
$184.14
87.8% downside
Current Fair Value
87.8% downsideOvervalued by 87.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $48.56 Billion |
|---|---|
| Enterprise Value | $38.80 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-154.06 |
| Beta | 0.04 |
| Outstanding Shares | 29,644,815 |
Return
| Return on Equity | 3.20% |
|---|---|
| Return on Assets | 2.77% |
| Return on Invested Capital | 3.84% |
Valuation & Multiples
| P/E Ratio | 21.01 |
|---|---|
| PEG | -6.2 |
| Price to Sales | 1.56 |
| Price to Book Ratio | 0.62 |
| Enterprise Value to Revenue | 1.35 |
| Enterprise Value to EBIT | 12.65 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About ORIENT BIO Inc.
125 employees
CEO: Jae-Jin Chang ORIENT BIO Inc. is a South Korean company active within the biotechnology sector. The firm specializes in providing laboratory animals and a range of equipment tailored for research environments. Established in 1959, the company initiall...